deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04685447

Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients

Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients Affected by COVID-19: Effects of 2 Different Dialysis Strategies

Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Conditions Covid19 Hemodialysis Complication Inflammatory Response
Interventions Expanded Hemodialysis for Covid19 maintenance hemodialysis patients Hemodialysis by protein-leaking dialyzer for Covid19 maintenance hemodialysis patients
Updated 5 times since 2021 Last updated: May 16, 2022 Started: Mar 16, 2020 Primary completion: Apr 20, 2020 Completion: May 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04685447, this NA trial focuses on Covid19 and Hemodialysis Complication and remains completed. Sponsored by IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Jun 2022 · 13 months · monthly snapshotRecruiting~Jun 2022 – ~Jul 2024 · 25 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jun 2022 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  4. May 2021 — Jun 2022 [monthly]

    Recruiting NA

  5. Jan 2021 — May 2021 [monthly]

    Recruiting NA

    First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
  • Universita degli Studi di Genova
Data source: Universita degli Studi di Genova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations